GENICA ALZHEIMER'S TEST DEMONSTRATES 95% SENSITIVITY
This article was originally published in The Gray Sheet
Executive Summary
GENICA ALZHEIMER'S TEST DEMONSTRATES 95% SENSITIVITY and 94% specificity in identifying patients with the disease in a study led by Leonard Scinto, Brigham and Women's Hospital, Boston, et al., the results of which were published in the Nov. 11 issue of Science. The test involves placing diluted drops of the drug tropicamide in patients' eyes and then measuring pupil dilation with a pupillometer. The test is considered positive if patients exhibit hypersensitivity in their pupil dilation response to the drug.